发明名称 |
Therapeutic agent for systemic bone disease and use thereof |
摘要 |
The present invention addresses the problem of providing a novel therapeutic strategy which has excellent therapeutic effects on systemic bone diseases caused by over-activation of FGFR3, in particular, achondroplasia and hypochondroplasia. A therapeutic agent for systemic bone disease is provided which comprises, as an active ingredient, meclizine or a pharmaceutically acceptable salt thereof. |
申请公布号 |
AU2014232030(A1) |
申请公布日期 |
2015.03.19 |
申请号 |
AU20140232030 |
申请日期 |
2014.02.20 |
申请人 |
NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY |
发明人 |
OHNO, KINJI;ISHIGURO, NAOKI;KITO, HIROSHI;MATSUSHITA, MASAKI |
分类号 |
A61K31/495;A23L1/30;A61P19/00;A61P43/00 |
主分类号 |
A61K31/495 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|